Physician profile
Aria Bryan
NPI 1356703003
$249.96
in general payments reported to CMS, 2019-2025
9 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.92 · 2022: $15.03 · 2023: $15.24 · 2024: $13.60 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.83 · Education: $77.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.83 |
| Education | $77.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $59.80 | 2025 | |
| Boston Scientific Corporation | $57.92 | 2019 | |
| Insmed, INC. | $38.24 | 2025 | Brinsupri, Arikayce |
| Glaxosmithkline, LLC. | $19.94 | 2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $15.98 | 2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $15.24 | 2023 | Entyvio |
| Genentech USA, INC. | $15.03 | 2022 | |
| Genzyme Corporation | $14.21 | 2025 | |
| La Jolla Pharmaceutical Company | $13.60 | 2024 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aria Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.